Literature DB >> 25982825

The Importance of NLRP3 Inflammasome in Heart Failure.

Brittany Butts1, Rebecca A Gary1, Sandra B Dunbar1, Javed Butler2.   

Abstract

Patients with heart failure continue to suffer adverse health consequences despite advances in therapies over the past 2 decades. Identification of novel therapeutic targets that may attenuate disease progression is therefore needed. The inflammasome may play a central role in modulating chronic inflammation and in turn affecting heart failure progression. The inflammasome is a complex of intracellular interaction proteins that trigger maturation of proinflammatory cytokines interleukin-1β and interleukin-18 to initiate the inflammatory response. This response is amplified through production of tumor necrosis factor α and activation of inducible nitric oxide synthase. The purpose of this review is to discuss recent evidence implicating this inflammatory pathway in the pathophysiology of heart failure.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; inflammasome; inflammation

Mesh:

Substances:

Year:  2015        PMID: 25982825      PMCID: PMC4516025          DOI: 10.1016/j.cardfail.2015.04.014

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  73 in total

Review 1.  Mechanisms and functions of inflammasomes.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

Review 2.  NLRP3 inflammasome as a novel player in myocardial infarction.

Authors:  Masafumi Takahashi
Journal:  Int Heart J       Date:  2014-03-14       Impact factor: 1.862

Review 3.  Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target.

Authors:  N Glezeva; J A Baugh
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

4.  Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta.

Authors:  B J Pomerantz; L L Reznikov; A H Harken; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

Review 5.  NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

Authors:  Jurg Tschopp; Kate Schroder
Journal:  Nat Rev Immunol       Date:  2010-02-19       Impact factor: 53.106

6.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Authors:  M Packer
Journal:  J Am Coll Cardiol       Date:  1992-07       Impact factor: 24.094

Review 7.  Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart.

Authors:  Soban Umar; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2009-07-19       Impact factor: 3.396

8.  Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis.

Authors:  Christopher A Koczor; Eva K Lee; Rebecca A Torres; Amy Boyd; J David Vega; Karan Uppal; Fan Yuan; Earl J Fields; Allen M Samarel; William Lewis
Journal:  Physiol Genomics       Date:  2013-05-21       Impact factor: 3.107

9.  Epigenetic switch at atp2a2 and myh7 gene promoters in pressure overload-induced heart failure.

Authors:  Tiziana Angrisano; Gabriele Giacomo Schiattarella; Simona Keller; Gianluigi Pironti; Ermanno Florio; Fabio Magliulo; Roberta Bottino; Raffaela Pero; Francesca Lembo; Enrico Vittorio Avvedimento; Giovanni Esposito; Bruno Trimarco; Lorenzo Chiariotti; Cinzia Perrino
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

10.  Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure.

Authors:  Mehregan Movassagh; Mun-Kit Choy; Martin Goddard; Martin R Bennett; Thomas A Down; Roger S-Y Foo
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more
  45 in total

1.  NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.

Authors:  Guangbi Li; Zhida Chen; Owais M Bhat; Qinghua Zhang; Justine M Abais-Battad; Sabena M Conley; Joseph K Ritter; Pin-Lan Li
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

2.  Cytokines profile of reverse cardiac remodeling following transcatheter aortic valve replacement.

Authors:  Juyong Brian Kim; Yukari Kobayashi; Tatiana Kuznetsova; Kegan J Moneghetti; Daniel A Brenner; Ryan O'Malley; Catherine Dao; Joseph C Wu; Michael Fischbein; D Craig Miller; Alan C Yeung; David Liang; Francois Haddad; William F Fearon
Journal:  Int J Cardiol       Date:  2018-11-01       Impact factor: 4.164

3.  Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway.

Authors:  Wei Gao; Hao Wang; Lin Zhang; Yang Cao; Ji-Zhang Bao; Zheng-Xia Liu; Lian-Sheng Wang; Qin Yang; Xiang Lu
Journal:  Endocrinology       Date:  2016-04-21       Impact factor: 4.736

4.  ASC Methylation and Interleukin-1β Are Associated with Aerobic Capacity in Heart Failure.

Authors:  Brittany Butts; Javed Butler; Sandra B Dunbar; Elizabeth J Corwin; Rebecca A Gary
Journal:  Med Sci Sports Exerc       Date:  2017-06       Impact factor: 5.411

5.  Fungal β-Glucan Activates the NLRP3 Inflammasome in Human Bronchial Epithelial Cells Through ROS Production.

Authors:  Yanhua Huang; Meng Hua; Xuefan Cui
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

Review 6.  The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin.

Authors:  Zaid H Maayah; Shingo Takahara; Jason R B Dyck
Journal:  Arch Toxicol       Date:  2020-08-27       Impact factor: 5.153

7.  Hydrogen Sulfide Therapy Suppresses Cofilin-2 and Attenuates Ischemic Heart Failure in a Mouse Model of Myocardial Infarction.

Authors:  Khoa Nguyen; Vinh Q Chau; Adolfo G Mauro; David Durrant; Stefano Toldo; Antonio Abbate; Anindita Das; Fadi N Salloum
Journal:  J Cardiovasc Pharmacol Ther       Date:  2020-05-11       Impact factor: 2.457

8.  Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition.

Authors:  Sumra Nazir; Ihsan Gadi; Moh'd Mohanad Al-Dabet; Ahmed Elwakiel; Shrey Kohli; Sanchita Ghosh; Jayakumar Manoharan; Satish Ranjan; Fabian Bock; Ruediger C Braun-Dullaeus; Charles T Esmon; Tobias B Huber; Eric Camerer; Chris Dockendorff; John H Griffin; Berend Isermann; Khurrum Shahzad
Journal:  Blood       Date:  2017-09-07       Impact factor: 22.113

9.  Methylation of Apoptosis-Associated Speck-Like Protein With a Caspase Recruitment Domain and Outcomes in Heart Failure.

Authors:  Brittany Butts; Rebecca A Gary; Sandra B Dunbar; Javed Butler
Journal:  J Card Fail       Date:  2015-12-14       Impact factor: 5.712

10.  Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge.

Authors:  Erfei Song; James Ws Jahng; Lisa P Chong; Hye K Sung; Meng Han; Cuiting Luo; Donghai Wu; Stellar Boo; Boris Hinz; Matthew A Cooper; Avril Ab Robertson; Thorsten Berger; Tak W Mak; Isaac George; P Christian Schulze; Yu Wang; Aimin Xu; Gary Sweeney
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.